Cerecin

• NCT01211782

  Phase 2/3, Withdrawn, 0 people, 30 Sept 2010

• Data‐driven cognitive composites predict Aβ‐related decline and progression to MCI: the ADOPIC study

  Consulting or advice, 1 Oct 2026

• Montreal Cognitive Assessment (MoCA) XpressO: Validation of a digital self-administered cognitive prescreening tool

  Shares or equity, 1 Apr 2024

Sources: pubmed.ncbi.nlm.nih.gov